PROLOCTI Trademark

Trademark Overview

On Thursday, July 24, 2014, a trademark application was filed for PROLOCTI with the United States Patent and Trademark Office. The USPTO has given the PROLOCTI trademark a serial number of 79152767. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 17, 2021. This trademark is owned by Novo Nordisk Health Care AG. The PROLOCTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for hemostasis management
prolocti

General Information

Serial Number79152767
Word MarkPROLOCTI
Filing DateThursday, July 24, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 17, 2021
Registration Number4693932
Registration DateTuesday, March 3, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for hemostasis management

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk Health Care AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Sunday, September 4, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, August 10, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, August 9, 2022INVALIDATION PROCESSED
Tuesday, May 17, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Sunday, November 21, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 17, 2021CANCELLED SECTION 71
Friday, August 6, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 5, 2015NOTIFICATION PROCESSED BY IB
Saturday, May 16, 2015FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 16, 2015FINAL DISPOSITION PROCESSED
Thursday, April 2, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, March 3, 2015REGISTERED-PRINCIPAL REGISTER
Friday, December 19, 2014NOTIFICATION PROCESSED BY IB
Tuesday, December 16, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 3, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 3, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 26, 2014NOTICE OF PUBLICATION
Monday, November 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 6, 2014ASSIGNED TO EXAMINER
Friday, October 10, 2014APPLICATION FILING RECEIPT MAILED
Monday, October 6, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 2, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

prolocti management hemostasis preparations pharmaceutical